Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on June 5, 2026

Pyra AI Launches Lead Seeker, an AI-Powered Prospecting Workspace for Revenue Teams
Radix brings 'Vision to Value' to the Forefront of Industrial AI  at Impact World Tour 2026
Antibacterial Products Market CAGR to be at 6.8% from 2026 to 2030 | $63.73 Billion Industry Revenue by 2030
Atrazine Market Drivers 2026-2030: Regional Outlook and Sizing Analysis
Advanced Ceramics Global Market Report 2026| Business Growth, Development Factors, Current and Future Trends till 2030
Agricultural Biologics Market to Reach USD $33.5 Billion by 2030 at 15.2% CAGR
Alcohol Ethoxylates Industry Report: Competitive Landscape and Future Prospects
Acid Dyes Market to Reach $4.77 Billion by 2030 with 7.2% CAGR
Vegan Cosmetics Market to Reach USD $29.8 Billion by 2030 at 8.9% CAGR
Willis Johnson Wealth Expands Specialized Financial Planning and Tax Services for Dow Professionals in Houston
Freight Market Outlook : Projected to Exceed USD 336.64 Billion by 2033 with a 5.3% CAGR | Coherent Market Insights
SGS announces complimentary PFAS testing at Eurobike 2026
Helium Market Growth Insights Shared in Detailed Report Till 2032 | Allied Market Research
Hyaluronic Acid Market 2026 | Historic Data And Growth Forecast, 2030
Squalene Industry to Generate Substantial Increment in Opportunities Through 2026 to 2030
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
Purecore Announces up to $1.5 Million Non-Brokered Private Placement
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.